| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |